<DOC>
	<DOCNO>NCT02894138</DOCNO>
	<brief_summary>In study investigator test hypothesis alteplase give intra coronary PCI reduce infarct size patient ST-elevation myocardial infarction ( STEMI ) impair microvascular function define value index microvascular resistance ( IMR ) &gt; 30 .</brief_summary>
	<brief_title>Optimal Coronary Flow After PCI Myocardial Infarction - Pilot Study</brief_title>
	<detailed_description>After coronary stenting , index microvascular resistance ( IMR ) measure invasively . Patients IMR &gt; 30 randomise 20 mg alteplase placebo ( NaCl ) administer culprit vessel microcatheter . Magnet resonance imaging ( MRI ) myocardium perform early ( 2-6 day ) late ( 3 month ) estimate primary endpoint ( infarct size ) . 10 non-randomised patient , IMR &lt; 30 , undergo follow-up randomise patient . Clinical event randomise non-randomised patient collect Swedish national registry telephone 3 12 month .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Criteria randomization : 1 . IMR measure culprit vessel &gt; 30 Criteria IMR measurement : 1 . Oral sign informed consent 2 . Males females 18 85 year age 3 . Diagnosis STelevation myocardial infarction ( STEMI ) include occlusion culprit vessel angiography 4 . Onset continuous symptom within 12 hour 5 . Have undergone PCI culprit vessel 6 . Subjects willing comply schedule visit test able willing provide inform consent 1 . Previously know ejection fraction &lt; 30 % 2 . Previous PCI culprit vessel 3 . Chronic total occlusion major vessel 4 . Any history bleeding diathesis , know coagulopathy , refuse blood transfusion 5 . Recent history know platelet count &lt; 100.000 cells/mm3 Hbg &lt; 10 g/dL 6 . Known reduced kidney function estimate glomerular filtration rate ( GFR ) &lt; 30 ml/min/1.73m2 . 7 . Previous hemorrhagic stroke 8 . Ongoing oral anticoagulation treatment 9 . Severe asthma require daily treatment 10 . Any mechanical complication ( e.g . ventricular septal defect , papillary muscle rupture , cardiac tamponade ) 11 . Atrioventricular block grade III 12 . Known inability undergo MRI investigation Permanent pacemaker Pronounced claustrophobia 13 . Known intolerance study drug 14 . Known intolerance adenosine 15 . Pregnancy 16 . Participation another investigational drug study 17 . Previous randomization OPTIMALPCI trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>